Markets· August 16, 2026 at 03:15 p.m.
Oppenheimer Upgrades Intuitive Surgical Stock, Setting a $500 Price Target
Key takeaways
- Intuitive Surgical upgraded from 'Perform' to 'Outperform'
- Oppenheimer sets a $500 price target for ISRG
- Analysts expect growth in robotic surgery and Intuitive's leading market position
Analysts at Oppenheimer have upgraded the medtech company Intuitive Surgical (ISRG) from 'Perform' to 'Outperform', predicting a 24.6% increase in stock value based on a $500 price target. The upgrade is driven by expectations of growth in robotic surgery and Intuitive's leading market position, despite increasing competition. The company is also developing AI capabilities for surgical applications.
